chr2-214792454-T-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_000465.4(BARD1):c.216-9A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 28)
Exomes 𝑓: 0.0037 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
BARD1
NM_000465.4 intron
NM_000465.4 intron
Scores
2
Splicing: ADA: 0.00002109
2
Clinical Significance
Conservation
PhyloP100: -0.559
Publications
0 publications found
Genes affected
BARD1 (HGNC:952): (BRCA1 associated RING domain 1) This gene encodes a protein which interacts with the N-terminal region of BRCA1. In addition to its ability to bind BRCA1 in vivo and in vitro, it shares homology with the 2 most conserved regions of BRCA1: the N-terminal RING motif and the C-terminal BRCT domain. The RING motif is a cysteine-rich sequence found in a variety of proteins that regulate cell growth, including the products of tumor suppressor genes and dominant protooncogenes. This protein also contains 3 tandem ankyrin repeats. The BARD1/BRCA1 interaction is disrupted by tumorigenic amino acid substitutions in BRCA1, implying that the formation of a stable complex between these proteins may be an essential aspect of BRCA1 tumor suppression. This protein may be the target of oncogenic mutations in breast or ovarian cancer. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
BARD1 Gene-Disease associations (from GenCC):
- BARD1-related cancer predispositionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- breast cancerInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- hereditary breast carcinomaInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 2-214792454-T-A is Benign according to our data. Variant chr2-214792454-T-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 489669.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000465.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| BARD1 | TSL:1 MANE Select | c.216-9A>T | intron | N/A | ENSP00000260947.4 | Q99728-1 | |||
| BARD1 | TSL:1 | c.159-9A>T | intron | N/A | ENSP00000480470.1 | Q99728-2 | |||
| BARD1 | TSL:1 | c.216-9A>T | intron | N/A | ENSP00000484976.2 | A0A087X2H0 |
Frequencies
GnomAD3 genomes AF: 0.00134 AC: 140AN: 104426Hom.: 0 Cov.: 28 show subpopulations
GnomAD3 genomes
AF:
AC:
140
AN:
104426
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0355 AC: 1960AN: 55262 AF XY: 0.0343 show subpopulations
GnomAD2 exomes
AF:
AC:
1960
AN:
55262
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00365 AC: 4712AN: 1289906Hom.: 0 Cov.: 33 AF XY: 0.00459 AC XY: 2910AN XY: 633326 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
4712
AN:
1289906
Hom.:
Cov.:
33
AF XY:
AC XY:
2910
AN XY:
633326
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
29
AN:
26874
American (AMR)
AF:
AC:
292
AN:
23480
Ashkenazi Jewish (ASJ)
AF:
AC:
255
AN:
20768
East Asian (EAS)
AF:
AC:
76
AN:
31386
South Asian (SAS)
AF:
AC:
1006
AN:
59266
European-Finnish (FIN)
AF:
AC:
1208
AN:
34114
Middle Eastern (MID)
AF:
AC:
11
AN:
4024
European-Non Finnish (NFE)
AF:
AC:
1702
AN:
1036804
Other (OTH)
AF:
AC:
133
AN:
53190
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.294
Heterozygous variant carriers
0
364
729
1093
1458
1822
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00134 AC: 140AN: 104442Hom.: 0 Cov.: 28 AF XY: 0.00153 AC XY: 77AN XY: 50390 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
140
AN:
104442
Hom.:
Cov.:
28
AF XY:
AC XY:
77
AN XY:
50390
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
30
AN:
27296
American (AMR)
AF:
AC:
8
AN:
10130
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
2558
East Asian (EAS)
AF:
AC:
3
AN:
3778
South Asian (SAS)
AF:
AC:
3
AN:
3234
European-Finnish (FIN)
AF:
AC:
19
AN:
6148
Middle Eastern (MID)
AF:
AC:
0
AN:
188
European-Non Finnish (NFE)
AF:
AC:
75
AN:
49006
Other (OTH)
AF:
AC:
0
AN:
1428
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.268
Heterozygous variant carriers
0
15
30
44
59
74
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
not specified (2)
-
-
1
Familial cancer of breast (1)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.